With the enhanced containment equipment and processes, the company aims to expand its service offering for dispensing and bottling solid dosage products.
Almac Clinical Services managing director Dr Robert Dunlop said demand for facilities equipped to handle compounds of a higher potency has increased recently.
"As a customer orientated company Almac saw an opportunity to meet the needs of its client base," Dunlop added.
"This development at our European and North American Headquarters is the latest example of how Almac constantly strives to advance its service offering to reflect the needs of the drug development industry."
The facilities that completed the successful installation and validation have become operational.